CLVT Stock - Clarivate Plc
Unlock GoAI Insights for CLVT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.56B | $2.63B | $2.66B | $1.88B | $1.25B |
| Gross Profit | $1.69B | $1.72B | $1.71B | $1.25B | $815.30M |
| Gross Margin | 66.0% | 65.5% | 64.1% | 66.6% | 65.0% |
| Operating Income | $-275,600,000 | $-734,700,000 | $-3,925,600,000 | $-87,000,000 | $-36,300,000 |
| Net Income | $-636,700,000 | $-911,200,000 | $-3,960,200,000 | $-270,500,000 | $-350,600,000 |
| Net Margin | -24.9% | -34.7% | -148.9% | -14.4% | -28.0% |
| EPS | $-0.96 | $-1.47 | $-6.26 | $-0.62 | $-0.63 |
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 17th 2025 | Morgan Stanley | Downgrade | Underweight | $3 |
| September 3rd 2025 | Wolfe Research | Initiation | Peer Perform | - |
| July 18th 2025 | Jefferies | Initiation | Hold | $4.5 |
| July 18th 2025 | Jefferies | Downgrade | Hold | $4.5 |
| November 6th 2024 | William Blair | Downgrade | Market Perform | - |
| December 15th 2023 | Wells Fargo | Downgrade | Underweight | $8 |
| October 16th 2023 | Jefferies | Upgrade | Buy | $8.5← $10 |
| September 8th 2023 | Barclays | Downgrade | Underweight | $7← $8 |
| August 25th 2023 | RBC Capital Mkts | Downgrade | Sector Perform | $8← $9 |
| August 7th 2023 | BofA Securities | Downgrade | Underperform | $6← $10 |
| August 4th 2023 | Wells Fargo | Downgrade | Equal Weight | $8← $15 |
| June 13th 2023 | Oppenheimer | Initiation | Outperform | $11 |
| March 15th 2023 | BofA Securities | Resumed | Neutral | - |
| February 6th 2023 | Morgan Stanley | Downgrade | Equal Weight | $12← $11 |
| July 13th 2022 | Wells Fargo | Initiation | Overweight | $20 |
Earnings History & Surprises
CLVTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 18, 2026 | $0.17 | — | — | — |
Q4 2025 | Oct 29, 2025 | $0.16 | $0.18 | +12.5% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.18 | $0.18 | 0.0% | = MET |
Q2 2025 | Apr 29, 2025 | $0.12 | $0.14 | +16.7% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $0.20 | $0.21 | +5.0% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $0.19 | $0.19 | 0.0% | = MET |
Q3 2024 | Aug 6, 2024 | $0.18 | $0.20 | +11.1% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $0.14 | $0.14 | 0.0% | = MET |
Q1 2024 | Feb 27, 2024 | $0.21 | $0.23 | +9.5% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.18 | $0.21 | +16.7% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.19 | $0.21 | +10.5% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.15 | $0.18 | +20.0% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $0.17 | $0.22 | +29.4% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.17 | $0.20 | +17.6% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $0.21 | $0.22 | +4.8% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $0.19 | $0.21 | +10.5% | ✓ BEAT |
Q1 2022 | Mar 10, 2022 | $0.22 | $0.23 | +4.5% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.16 | $0.16 | 0.0% | = MET |
Q3 2021 | Jul 29, 2021 | $0.18 | $0.17 | -5.6% | ✗ MISS |
Latest News
Morgan Stanley Downgrades Clarivate to Underweight, Lowers Price Target to $3
📉 NegativeClarivate Launches Cortellis Regulatory Intelligence AI Assistant Powered By Agentic AI For Faster, More Confident Decisions
📈 PositiveClarivate Announced The Launch Of Derwent Patent Monitor To Streamline Intellectual Property And Research And Development Collaborative Patent Reviews When Determining Patentability, Assessing Freedom To Operate And Evaluating Opposition Or Assertion
📈 PositiveCLVT stock has given up its prior gain. Clarivate shares were trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
➖ NeutralClarivate shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates. Also, the company raised its FY25 GAAP EPS guidance.
📈 PositiveClarivate Raises FY2025 GAAP EPS Guidance from $(0.49)-$(0.39) to $(0.48)-$(0.38) vs $(0.38) Est
📈 PositiveClarivate Affirms FY2025 Adj EPS Guidance of $0.60-$0.70 vs $0.65 Est; Raises FY2025 Sales Guidance from $2.280B-$2.400B to $2.420B-$2.450B vs $2.385B Est
📈 PositiveClarivate Q3 Adj. EPS $0.18 Beats $0.16 Estimate, Sales $623.100M Beat $570.341M Estimate
📈 PositiveWinbond Adopts Clarivate IPfolio Cloud Platform To Streamline IP Management And Drive Digital Transformation
📈 PositiveClarivate Launches Innography AI Classifier With 97% First-Pass Accuracy And SEP Analyzer For Competitive Benchmarking And Patent Analysis
📈 PositiveWolfe Research Initiates Coverage On Clarivate with Peer Perform Rating
➖ NeutralFrequently Asked Questions about CLVT
What is CLVT's current stock price?
What is the analyst price target for CLVT?
What sector is Clarivate Plc in?
What is CLVT's market cap?
Does CLVT pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to CLVT for comparison